Affordable Access

Ancient DNA research goes nuclear

Publication Date
  • Science And Society
  • Political Science


Ancient DNA research goes nuclear science & society EMBO reports VOL 7 | NO 2 | 2006 ©2006 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION analysis 136 biotech and life sciences worldwide as part of a larger project to map human technologi- cal development (Fig 1). “Maps can help answer or at least address a number of key questions,” said Hoffman. “Where around the world is biotech really happening or beginning to happen? How important is eco- nomic geography now that the life sciences are spilling out of university, governmental and industrial laboratories into regional economies? Where is the search for ‘biotech gold’ breaking down national boundaries and political jurisdictions, with different regions and different countries banding together to compete in the global economy?” Indeed, the biotech-clustering craze hasalready created another level of complex-ity: meta-clusters. These are transnational networks of clusters operating in geographi- cally connected countries. Europe, in partic- ular, is a fertile place for such initiatives. The latest is EuroBioCluster South, which was announced at the 2005 BioVision conference held in April 2005 in Lyon, France. The pro- ject will combine bioclusters from an area stretching from Heidelberg, Germany, to Barcelona, Spain, “to stimulate a supra- regional dynamic of scientific and technolog- ical growth and international outreach,” according to an official press release (Grand Lyon, 2005). The EuroBioCluster’s potential is expected to exceed that of Seattle, San Diego and San Francisco combined, and it will have “the largest concentration of life-science enterprises in the world, with the presence of both major groups and start-ups, research centres, universities and institutions.” ScanBalt is another main cross-border effort in biotech and life-sciences develop- ment, encompassing 11 countries and 85 million people in Northern Europe with 60 universities and 870 biotech-related compa- nies. “We do not consider ScanBalt to be a meta-cluster bu

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times